Search

Simple Summary: Infectious bursal disease virus (IBDV) is a potent immunosuppressive, persistent pathogen that can thrive in a range of environmental conditions and withstand even potent disinfectants. The common circulating pathotypes of IBDV in Egypt are classical virulent, attenuated, very virulent IBDV, and novel variant (nVarIBDV). The current study describes the incidence of nVarIBDV in 18 Egyptian chicken flocks although they were vaccinated against IBD. Partial sequence analysis of viral protein 2 (VP2) in two obtained isolates identified them as nVarIBDV (genotype A2d) exhibiting 100% identity to SD-2020 and 99.5–98.1% similarity to ZD-2018-1, QZ, GX and SG19 strains. Similarity to USA variant strains was 95.5–92.6%. Moreover, the similarities in the aa of the VP2 hypervariable region of both isolates to vaccine strains were 86–90.4%. Histopathological examination of both the bursa of Fabricius and spleen collected from diseased chickens in flock no. 18 revealed severe atrophy. In conclusion, this study identified the nVarIBDV genotype which is identical to the nVarIBDV circulating in China. Further studies are required to investigate the epidemiological situation of this novel genotype across the country, and to assess various vaccine protections against nVarIBDV. Additionally, it is crucial to incorporate nVarIBDV into the inactivated vaccines administered to breeder chickens prior to egg production to ensure complete protective and specific maternal immunity in their offspring during their first three weeks of life. After an extended period of detecting classical virulent, attenuated, and very virulent IBDV, a novel variant (nVarIBDV) was confirmed in Egypt in this study in 18, IBD vaccinated, chicken flocks aged 19–49 days. Partial sequence of viral protein 2 (VP2) [219 aa, 147–366, resembling 657 bp] of two obtained isolates (nos. 3 and 4) revealed nVarIBDV (genotype A2d) and OR682618 and OR682619 GenBank accession numbers were obtained. Phylogenetic analysis revealed that both nVarIBDV isolates were closely related to nVarIBDV strains (A2d) circulating in China, exhibiting 100% identity to SD-2020 and 99.5–98.1% similarity to ZD-2018-1, QZ, GX and SG19 strains, respectively. Similarity to USA variant strains, belonging to genotypes A2b (9109), A2c (GLS) and A2a (variant E), respectively, was 95.5–92.6%. Also, the VP2 hypervariable region in those two, A2d, isolates revealed greater similarities to Faragher 52/70 (Vaxxitek®) at 90.4% and to an Indian strain (Ventri-Plus®) and V217 (Xtreme®) at 89.7% and 86–88.9% in other vaccines. Histopathological examination of both the bursa of Fabricius and spleen collected from diseased chickens in flock no. 18 revealed severe atrophy. In conclusion, further studies are required to investigate the epidemiological situation of this novel genotype across the country, and to assess various vaccine protections against nVarIBDV. Additionally, vaccination of breeders with inactivated IBD vaccines including this nVarIBDV is essential to obtain specific maternal antibodies in their broilers. [ABSTRACT FROM AUTHOR]

Global spread and regional endemicity of H5Nx Goose/Guangdong avian influenza viruses (AIV) pose a continuous threat for poultry production and zoonotic, potentially pre-pandemic, transmission to humans. Little is known about the role of mutations in the viral neuraminidase (NA) that accompanied bird-to-human transmission to support AIV infection of mammals. Here, after detailed analysis of the NA sequence of human H5N1 viruses, we studied the role of A46D, L204M, S319F and S430G mutations in virus fitness in vitro and in vivo. Although H5N1 AIV carrying avian- or human-like NAs had similar replication efficiency in avian cells, human-like NA enhanced virus replication in human airway epithelia. The L204M substitution consistently reduced NA activity of H5N1 and nine other influenza viruses carrying NA of groups 1 and 2, indicating a universal effect. Compared to the avian ancestor, human-like H5N1 virus has less NA incorporated in the virion, reduced levels of viral NA RNA replication and NA expression. We also demonstrate increased accumulation of NA at the plasma membrane, reduced virus release and enhanced cell-to-cell spread. Furthermore, NA mutations increased virus binding to human-type receptors. While not affecting high virulence of H5N1 in chickens, the studied NA mutations modulated virulence and replication of H5N1 AIV in mice and to a lesser extent in ferrets. Together, mutations in the NA of human H5N1 viruses play different roles in infection of mammals without affecting virulence or transmission in chickens. These results are important to understand the genetic determinants for replication of AIV in mammals and should assist in the prediction of AIV with zoonotic potential. Author summary: Avian influenza viruses (AIV) including viruses of the H5Nx Goose/Guangdong-lineage caused hundreds of human infections and fatalities worldwide and pose a continuous zoonotic and pandemic threat. It is important to understand the role of mutations that support AIV-infection in mammals after bird-to-human transmission. Here, we describe the prevalence and the role of mutations in the viral neuraminidase (NA), which is mainly responsible for virus release from infected cells, preferentially selected in human H5N1 viruses. Compared to their avian ancestors, human-like H5N1 had less NA in virus particles and exhibited lower NA activity conferred mainly by the L204M substitution. Furthermore, NA mutations increased the binding of H5N1 to human-type receptors, acted synergistically to confer high virus replication in avian and human cells and/or modulated virulence and replication in mice, but not in chickens. This study is important to understand the genetic and biological properties of human AIV and will help to predict zoonotic potential AIV. [ABSTRACT FROM AUTHOR]

The global spread of avian influenza virus (AIV) of clade 2.3.4.4b since 2016 has caused severe losses in wild birds and poultry and has posed a risk for the infection of mammals including humans. The vaccination of poultry has been used to limit the spread of the virus and mitigate its socioeconomic impact. Here, we describe H5N8 epidemics in chickens, turkeys and ducks from different localities in Egypt from 2019 to 2021. About 41.7% (n = 88/211) flocks were tested positive by RT-qPCR for H5N8 viruses with prevalence rates of 45.1% (n = 65/144) and 34.3% (n = 23/67) in vaccinated and non-vaccinated flocks, respectively. A sequence analysis of the hemagglutinin and neuraminidase genes indicated not only the multiple introduction events of H5N8 viruses in Egypt but also the establishment of endemic viruses in commercial poultry in 2020/2021. The recent H5N8 viruses in poultry in Egypt are genetically distinct from the majority of licensed vaccines used in the field. Together, our findings indicate that poultry in Egypt is an endemic center for clade 2.3.4.4b in the Middle East. The efficiency of current vaccines should be regularly evaluated and updated to fully protect poultry flocks in Egypt against H5N8 viruses. [ABSTRACT FROM AUTHOR]

Background: Newcastle disease (ND) causes severe economic losses in poultry industry worldwide. Egyptian poultry industry suffered from severe economic losses since the isolation of Velogenic Newcastle disease virus (vNDV) genotype VIId in 2011 and up till now despite the use of different vaccination programs. So, this study aimed to isolate and characterize the vNDV from a total of 120 poultry flocks from ten provinces in the Egyptian Delta region with a history of respiratory manifestation, high mortalities or a decrease in egg production between 2015 and 2019. Seventy-three samples' allantoic fluid (73/120, 60.8%) were positive for hemagglutination with chicken RBCs. These samples were submitted to molecular examination using qRT-PCR specific primers for AOAV-1, highly pathogenic avian influenza (HPAI-H5), low pathogenic avian influenza (LPAI-H9) and infectious bronchitis virus (IBV). Results: Fifty samples (50/120: 41.6%) were confirmed positive for AOAV-1, based on genetic analysis of matrix and fusion protein. The co-infection rate of other respiratory viral diseases examined was 1.6, 14.1, and 4.1%, for HPAI-H5, LPAI-H9, and IBV, respectively. Biologically, the intracerebral pathogenicity index of ten selected AOAV-1 isolates ranged from 1.70 to 1.98, which indicated the velogenic nature of these isolates. All the sixteen sequenced isolates were AOAV-1 genotype VII.1.1. The full F gene sequence of six examined AOAV-1 VII.1.1 isolates contained the seven neutralizing epitopes, and the glycosylation motif of six-potential sites for N linked glycosylation at residues 85, 191, 366, 447, 471, and 541. Conclusion: It could be concluded that the high prevalence of AOAV-1 genotype VII.1.1 in the Egyptian chicken flocks despite the intensive vaccination with live and killed ND vaccines, as all the 16 isolates tested were belonged to this genotype. Homologous vaccination is badly needed to control and reduce the spread of AOAV-1 genotype VII.1.1infection in Egyptian poultry flocks. [ABSTRACT FROM AUTHOR]

Ornithobacterium rhinotracheale (ORT) and Mycoplasma gallisepticum (MG) are bacterial causes of respiratory diseases in chickens. The objective of this work was to investigate the possible interaction between ORT and MG in respiratory problem of broiler chickens. The experimental study confirmed that ORT infection alone could induced respiratory signs as (rales, nasal discharge), post mortem lesions (unilateral and bilateral pneumonia) and histopathological changes in tracheas, lungs and air sacs. Moreover, co-infection of ORT with MG induced severe respiratory signs like pneumonia, edema and severe inflammatory cell infilteration in lungs and air sacs than that observed in chickens infected with ORT or MG alone. ORT and MG were successfully re-isolated by PCR from tracheal swabs at 3, 7 and 14 days post infection. The results showed the synergistic effect of mixed infection of ORT and MG in broiler chickens regarding clinical signs, PM lesions, mortality rate, body weight, reisolation and histopathological examination. [ABSTRACT FROM AUTHOR]

Background: H9N2 avian influenza virus is endemic in Egyptian poultry flocks. The role of the live viral vaccines such as LaSota in exaggeration of the clinical picture of H9N2 infection under field conditions is significantly important leading to severe economic losses due to higher mortality and lower growth performance. This experiment was designed to identify the possible interaction between experimental infection with H9N2 virus and NDV live vaccine (LaSota strain) in broiler chickens. Six groups each of 20 broiler chicks were used. Three groups (G1–3) were infected with H9N2 and vaccinated with LaSota, 3 days before, at the same day or 3 days post vaccination (dpv), while the remaining groups (G4–6) were non-vaccinated infected, vaccinated non-infected and non-vaccinated non-infected. Results: The highest mortality rate (37.5%) was noticed in chickens of G1 (H9N2 infected 3 days prior LaSota vaccination). Also, this bird group had the most severe clinical signs, histopathological lesions and the longest viral shedding for 9 days post infection (dpi). In the 2nd and 3rd groups, the mortality rate was the similar (31.2%) with less pronounced clinical signs, histopathological lesions and H9N2 shedding was for only 6 dpi with the least shedding quantity in chickens of G3. The control non-vaccinated infected chickens (G4) had 18.7% mortality with the least degree of clinical signs, lesions and the highest viral shedding quantity but only for 6 dpi. At 35 days of age, there was a statistical significant decrease (P < 0.05) in chicken’s body weight of all H9N2 infected groups from G1 to G4 compared to non-infected control groups, G5 and G6 respectively. Conclusion: It was clear that laSota vaccination significantly affect H9N2 infection in broiler chickens regarding clinical signs, mortality rate, lesions, performance and viral shedding. [ABSTRACT FROM AUTHOR]

Diminishing the cost of broiler chicken diet is a critical issue in the poultry industry. Numerous studies were performed to achieve this pivotal objective by diet supplementation with alternative feed additives. In the current study, low-energy broiler rations were supplemented with different commercial multienzyme formulations to minimize the cost, and increase the digestibility and absorption of the digested macronutrients. Cobb Avian 48 broiler chicks (mixed sex, 1-d-old, n = 3120) were randomly allocated into six groups, and each group was subdivided into four replicates (130 birds per replicate). The birds were randomly allocated into a control group fed basal diet (CB); control group fed low-energy diet (CL); and birds fed low-energy diets supplemented with different enzyme formulations. The enzyme formulations used were Xylam 500® (CLX group), Hemicell® (CLH group), Avizyme® (CLA group), and Megazyme® (CLM group,) following the doses recommended by the manufacturers. The growth performance of CLA and CLH group birds was significantly improved when compared with CL. In comparison with CB, Avizyme® significantly (p < 0.001) increased the intestinal PEPT1, GLUT2, ACC, and IL-2 expression; PEPT1 facilitates the absorption of micronutrients. In conclusion, exogenous multienzyme complexes may be included in the low-energy diet to enhance the performance of broiler chickens (Avizyme® ˃ Hemicell® ˃ Megazyme®), and reduce the diet cost by up-regulating the expression of intestinal nutrient transporter genes, and improving the immunity and serum biochemical parameters of broiler chickens. [ABSTRACT FROM AUTHOR]

The protection of the commercially available vaccines was evaluated against two Egyptian variant IBV isolates that was found to be related to IS/885 variant II strain by 86% and 84% respectively in commercial broiler chickens. The protection assessment was detected by clinical signs, gross lesions, detection of viral shedding in tracheal and cloacal swabs, estimation of kidney function tests (Creatinine and Uric acid), detection of specific IBV antibody titer and histopathological examination. No significant protection could be provided against both challenging viruses using the classical live H120, Ma5 vaccines at day 1 and 14 of age respectively. Also no significant protection could be provided using 2 different inactivated vaccines at day 5 of age. The results indicated that the used vaccine strains and the challenging IBV field isolates are not the same protecteotype, therefore, change in the program of field vaccination is required to obtain a relative improvement of protection. [ABSTRACT FROM AUTHOR]

Gallibacterium anatis and Mycoplasma gallisepticum are bacterial pathogens affecting the respiratory tract of broiler chickens. Tracking the mixed experimental infection effect with G. anatis and M. gallisepticum in broiler chickens regarding clinical signs, performance, PM and histopathological lesions was the aim of this work. Birds inoculated with G. anatis (G2) or M. gallisepticum (G4) alone showed less severe clinical signs and gross pathological lesions in the respiratory tract. While, co-infection with G. anatis and M. gallisepticum (G3) exaggerated the clinical signs like rales, sneezing, nasal discharge, coughing, lacrimation and open mouth breathing and also gross and microscopical lesions which appeared as severe conjunctivitis with hemorrhagic congestive tracheitis, pneumonia and hyperplasia of the epithelium lining of trachea as compared to other groups which were infected with single pathogen or control negative group (G1). In conclusion, G. anatis produce less severe clinical signs and lesions regarding respiratory system than coinfection with M. gallisepticum which may be a most important factor enhancing the pathogenicity of G. anatis under field conditions [ABSTRACT FROM AUTHOR]

Supplementation of exogenous enzymes in chickens has been widely practiced, yet mechanisms responsible are not fully delineated. To investigate the effects of the dietary lysozyme on the growth performance and immunity of broiler chickens, a total of 120 one-day-old Ross 308 chicks were randomly allocated into four groups, each having three replicates (30 birds/group). The chicks were fed the starter (1–21 d) and grower (22–35 d) diets supplemented with 0 (control), 70 (LYZ70), 90 (LYZ90) and 120 (LYZ120) g of lysozyme 10%® per ton of basal diet for five weeks. The results revealed significant improvement in the growth performance and gut environment. There were significant decreases (P < 0.05 or 0.01) in the harmful fecal Coliform and Clostridia and an increase (P ˂ 0.05) in the beneficial Lactobacillus in the lysozyme-supplemented groups, especially in LYZ90. Moreover, the mRNA expressions of Cu, Zn-superoxide dismutase (SOD1), glutathione peroxidase (GSH-Px), interferon-gamma (IFN-γ), interleukin-10 (IL-10), and interleukin-18 (IL-18) were upregulated in response to lysozyme supplementation. In comparison to control, LYZ90 fed birds had a significant increase (P < 0.01) in the GSH-Px gene expression that enhances the antioxidant status of the gut. Expression of the biomarkers involved in the gut non-specific immunity indicated significant increases in the mRNA expression of INF-γ (P < 0.001), IL-10 (P < 0.001), and IL-18 (P < 0.05) in LYZ90 group. Also, serum globulin levels were significantly elevated (P ˂ 0.05) in lysozyme-supplemented groups. Histologically, the intestinal villi length and crypts depth were also enhanced (P ˂ 0.05) by dietary lysozyme supplementation. In conclusion, supplementation of broiler chickens with exogenous lysozyme, especially at 90 g of lysozyme per ton of basal diet dose rate, improved the growth performance, gut antioxidant status, and nonspecific immunity of broiler chickens. [ABSTRACT FROM AUTHOR]

Background: Vaccination of poultry to control highly pathogenic avian influenza virus (HPAIV) H5N1 is used in several countries. HPAIV H5N1 of clade 2.2.1 which is endemic in Egypt has diversified into two genetic clades. Clade 2.2.1.1 represents antigenic drift variants in vaccinated commercial poultry while clade 2.2.1.2 variants are detected in humans and backyard poultry. Little is known about H5N1 infection in vaccinated turkeys under field conditions. Case presentation: Here, we describe an HPAI H5N1 outbreak in a vaccinated meat-turkey flock in Egypt. Birds were vaccinated with inactivated H5N2 and H5N1 vaccines at 8 and 34 days of age, respectively. At 72nd day of age (38 days post last vaccination), turkeys exhibited mild respiratory signs, cyanosis of snood and severe congestion of the internal organs. Survivors had a reduction in feed consumption and body gain. A mortality of ~29% cumulated within 10 days after the onset of clinical signs. Laboratory diagnosis using RT-qPCRs revealed presence of H5N1 but was negative for H7 and H9 subtypes. A substantial antigenic drift against different serum samples from clade 2.2.1.1 and clade 2.3.4.4 was observed. Based on full genome sequence analysis the virus belonged to clade 2.2.1.2 but clustered with recent H5N1 viruses from 2015 in poultry in Israel, Gaza and Egypt in a novel subclade designated here 2.2.1.2a which is distinct from 2014/2015 2.2.1.2 viruses. These viruses possess 2.2.1.2 clade-specific genetic signatures and also mutations in the HA similar to those in clade 2.2.1.1 that enabled evasion from humoral immune response. Taken together, this manuscript describes a recent HPAI H5N1 outbreak in vaccinated meat-turkeys in Egypt after infection with a virus representing novel distinct 2.2.1.2a subclade. Conclusions: Infection with HPAIV H5N1 in commercial turkeys resulted in significant morbidity and mortality despite of vaccination using H5 vaccines. The isolated virus showed antigenic drift and clustered in a novel cluster designated here 2.2.1.2a related to viruses in poultry in Israel, Gaza and Egypt. Enforcement of biosecurity and constant update of vaccine virus strains may be helpful to protect vaccinated birds and prevent spillover infection to neighbouring countries. [ABSTRACT FROM AUTHOR]

Avian nephritis virus is a new circulating virus in Europe, Australia, and Japan, this virus lead to growth retardation of young chickens by causing interstitial nephritis. Investigation was done in 5 Egyptian governorates (North Sinai, El-Minoufiya, El- Gharbia and El-Behera and Kafr-Elsheikh) on 28 broiler chicken flocks and all the flocks were negative for Avian nephritis virus. In addition, we continued the detection of IBV in the same 28 broiler chicken flocks, resulting that 11 flocks out of 28 flocks, were positive for IBV. Regarding spike glycoprotein (S1) gene, sequencing was done to 5 isolates, which showed that they belonged to Eg/12120s/2012 spike glycoprotein (SP1) gene variant 2. Protectotyping was done using 2 isolates, and 3 types of IB live attenuated vaccines (H120, Ma5, IB primer). In conclusion, this study recorded the extensive circulation of variant 2 IBV in Egyptian broiler chickens. Regarding the pathogenicity of the tested variant and cross protection with available live IB vaccines, it was clear that there no complete cross protection against IBV isolates although of using live attenuated IB vaccines so there a need for further studies to define a more effective program for IB control. [ABSTRACT FROM AUTHOR]

The aim of the present study was to investigate the incidence of G. anatis infection in commercial broiler and layer chickens in El-behira and Alexandria governorates, Egypt. A total of 64 chicken flocks (53 broiler, 6 layer and 5 breeder flocks) suffering from rales, sneezing and decreased egg production (in layer and breeder flocks) were examined by collecting swabs from trachea, oviduct and ovarian tissues. The molecular identification for the suspected samples, using PCR primers targeted the 16S rRNA (1133fgal) and 23S rRNA (114r) genes revealed 23.43% (15/64) positive isolates of G. anatis. The invitro antibiotic sensitivity testing was done and revealed that almost all isolates were sensitive to cefotaxime, norfloxacin, doxycycline and florfenicol. According to the clinical signs, PM lesions and histopathological lesions in commercial broiler chickens infected experimentally there was a significant differences in the pathogenicity in commercial broiler chickens among the 10 isolates used. [ABSTRACT FROM AUTHOR]

Simple Summary: Rations for broilers can be safely supplemented with probiotics such as active Saccharomyces cerevisiae (SC) yeast to stimulate oxidative reactions and immune response against stress and infectious agents. The current study suggested that SC yeast enhanced antioxidant capacity, growth rate, immune organ weights, immune response and the survival rate of broilers after Avian Influenza virus challenge at 38 days of age. Probiotics, such as active yeasts, are widely used to enhance poultry production and reduce feeding costs. This study aimed to investigate the antioxidant and immune responses of broilers to different concentrations of active Saccharomyces cerevisiae (SC) when supplemented to two types of diets. A total of 216 1-day-old Arbor Acres unsexed chicks were used in a factorial design, involving two feeds (regular- versus low-density diet) and three concentrations of SC (0%, 0.02% and 0.04%). The results revealed that the low-density diet reduced the body weight and production index of broilers. The addition of SC improved the production index more than the control diet. Total antioxidant capacity (TAC), alanine aminotransferase (ALT), aspartate aminotransferase (AST) and eosinophils were significantly higher in response to the regular-density diet than the low-density diet; however, phagocytic activity (PA), lymphocyte and lysozyme activity (LYS) were lower. Saccharomyces cerevisiae reduced ALT, AST, malondialdehyde (MAD) and TAC more than the standard set, but improved packed cell volume (PCV), hemoglobin (Hgb), red blood cells (RBCs), lymphocytes, monocytes, heterophils, phagocytic index (PI) and the immune response to Newcastle disease virus (NDV) and avian influenza (AI). In conclusion, supplementation of a regular- or low-density diet with SC at a concentration of 0.02% or 0.04% improved the antioxidant parameters, immune status and production index of broilers against stress and infectious agents. [ABSTRACT FROM AUTHOR]

Simple Summary: The biological activity of quercetin is diverse, particularly antioxidant, antimicrobial, and antibacterial. The impacts of quercetin nutritional supplementations on growth performance, humoral immunity, gut microbiota and mRNA in broiler chickens were recorded. Quercetin was fed to groups of broiler chickens at concentrations of 200, 400, and 800 ppm, and a control group was supplemented with a basal diet. Results revealed that quercetin dietary supplementation numerically improved the growth performance traits and significantly increased (p < 0.05) the European production efficiency factor (EPEF) in the 200 ppm group. The total coliforms and Clostridium perfringens were decreased (p < 0.05) in quercetin-supplemented groups. Conversely, Lactobacillus counts were increased (p < 0.05), due to improvement of the gut microbiota environment in quercetin-supplemented groups. Moreover, the mRNA expression of intestinal Cu/Zn-superoxide dismutase (SOD1), glutathione peroxidase (GSH-Px) and nutritional transporters, including glucose transporter 2 (GLUT2), peptide transporter 1 (PEPT1), and fatty acid synthase (FAS) genes, were significantly upregulated in quercetin-supplemented groups. Quercetin enhanced intestinal morphometry. We can suggest quercetin supplementation in broiler chickens by levels between 200 and 400 ppm to enhance their development and gut environment. [ABSTRACT FROM AUTHOR]

Simple Summary: Newcastle disease is an acute fatal disease of poultry. All broiler chickens and 8/15 pigeons were killed when infected intramuscularly (IM), while 7/10 chickens and only 1/15 pigeons were killed when infected intranasally (IN) with the virus in an experimental setting. Chickens in contact with infected pigeons developed severe respiratory, digestive and nervous signs. The mortality rates in chickens in contact with IM and IN infected pigeons were 2/5 and 3/5, respectively. Chickens in contact with IM infected pigeons had higher viral shedding titres than those in contact with IN infected pigeons. Free-range pigeons are considered an efficient carrier and transmitter of NDV-VIId to commercial broiler chickens raised in open houses. Newcastle disease is an acute fatal disease of poultry. The aim of this study was to determine the dynamics of the transmission of avian avulavirus (velogenic viscerotropic Newcastle disease-genotype VIId) from either intramuscularly (IM)- or intranasally (IN) infected 8-week-old Egyptian Baladi pigeons in contact with commercial Arbor Acres broiler chickens (4 weeks of age). The mortality of IM infected chickens and pigeons was 10/10 for chickens and 8/15 for pigeons, while the mortality of IN infected chickens and pigeons was 7/10 for chickens and only 1/15 for pigeons. The concentration of viral shedding in the oropharynx was higher than that in the cloaca for both IN and IM infected pigeons. Pigeons infected IN continued shedding the virus from the oropharynx from the 4th day post-infection (dpi) up to the 16th dpi, while IM infected pigeons stopped oropharyngeal shedding at the 11th dpi. Chickens in contact with infected pigeons developed severe respiratory, digestive and nervous signs. The mortality rates in chickens in contact with IM and IN infected pigeons were 2/5 and 3/5, respectively. Chickens in contact with IM infected pigeons showed higher viral shedding titres in both the oropharynx and cloaca than chickens in contact with pigeons infected IN. In conclusion, free-range pigeons are considered an efficient carrier and transmitter of NDV-VIId compared to commercial broiler chickens raised in open houses. [ABSTRACT FROM AUTHOR]

Simple Summary: After banning the use of antibiotics as growth promoters in poultry production, scientists had to find efficient and safe alternatives. Because of their useful properties, two types of probiotic bacteria were chosen to be administrated in a broiler diet, either individually or combined. Useful effects were obtained regarding improvements of growth performance, and immunity. A total of 120 1-day-old commercial Cobb chicks were used to study the effects of Clostridium butyricum (C. butyricum) and/or Saccharomyces cerevisiae (S. cerevisiae) on growth performance, intestinal health, and immune status in broilers. The experimental groups were as follows: G1; basal diet (BD), G2; basal diet (BD) plus C. butyricum preparation at 0.5 g/kg diet, G3; BD plus S. cerevisiae preparation at 0.5 g/kg diet, G4; BD plus 0.25 g/kg C. butyricum preparation plus 0.25 g/kg S. cerevisiae. Results showed that the total body weight gain, feed conversion efficiency, and protein efficiency ratio were significantly higher (p < 0.05) in the G4 group than in the other groups. The mortality percentage was reduced in the probiotic-supplemented groups. The villi height was elongated, and the villus height/crypt depth ratio was significantly increased in G2 and G4 chicks, compared to those in the control. The crypt depth was significantly decreased in all the probiotic-supplemented groups. Hemagglutination inhibition titers for Newcastle disease virus (NDV) were markedly increased in G2 and G4 chicks at 35 days of age, compared to those in G3 and control chicks. These results showed that dietary supplementation of a combined mixture of C. butyricum and S. cerevisiae in an equal ratio (G4) was more effective in improving growth performance, immune status, and gut health of broilers, compared with individual supplementation at a full dose. [ABSTRACT FROM AUTHOR]